JDD Corner

Placement of High Dose Neurotoxins for Treatment-Resistant Rosacea
rosaceaRosacea is a chronic inflammatory skin condition characterized by facial flushing, erythema, telangiectasias, and papulopustular lesions. Treatment for rosacea includes limiting inciting factors and reducing inflammation with topical and oral therapies. Traditional therapies primarily focus on the papulopustular or background erythematotelangiectatic component of rosacea, leaving symptoms of flush …
rosacea
Leukemia Cutis in Skin of Color
leukemia cutisThe various presentations of many dermatologic conditions among various skin types are slowly being elucidated throughout the recent years. These differences present as an issue as it leads to delayed diagnosis, treatment, and poorer quality of life. Herein, JDD authors  Susuana Adjei MD, et al.  present the characteristics of leukemia cutis in a skin of color patient with diagnosed chronic myel …
leukemia cutis
JDD August 2023 Issue Highlights | Special Focus: Psoriasis
psoriasisWith a special focus on the topic of psoriasis, check out highlights from the August issue of the Journal of Drugs in Dermatology (JDD) straight from the JDD Editor’s desk: Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis delves into the expert guidance provided by the Psoriasis Expert Group (PEG), encompassing nine crucial statements that offer com …
psoriasis
JDD July 2023 Issue Highlights | Special Focus: Bridging The Gap in Dermatology
dermatologyCheck out this month’s issue highlights straight from the JDD Editor’s desk: Assessing Implicit Bias in Dermatology analyses the results of a survey conducted with 220 dermatologists to determine the necessity for enhanced training and resources in order to support the increasingly diverse population. Modified Fitzpatrick Scale-Skin Color and Reactivity presents a new system that can hel …
dermatology
Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series
isotretinoin In this brief communication, JDD authors T. Roxana Ghadimi BS, Michael J. Martinez BS, and Evan A. Rieder MD present self-reported long-term, remote side effects to isotretinoin that dermatologists must be aware of. INTRODUCTION Isotretinoin is considered the gold standard treatment for severe nodulocystic acne, though it has been the subject of controversy in the media for concerns relate …
isotretinoin